• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个古老的 PROKR2 启动子突变会损害人类生殖能力。

An ancient founder mutation in PROKR2 impairs human reproduction.

机构信息

Harvard Reproductive Endocrine Sciences Center and the Reproductive Endocrine Unit of the Department of Medicine, Massachusetts General Hospital, Boston 02114, MA, USA.

出版信息

Hum Mol Genet. 2012 Oct 1;21(19):4314-24. doi: 10.1093/hmg/dds264. Epub 2012 Jul 5.

DOI:10.1093/hmg/dds264
PMID:22773735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3441126/
Abstract

Congenital gonadotropin-releasing hormone (GnRH) deficiency manifests as absent or incomplete sexual maturation and infertility. Although the disease exhibits marked locus and allelic heterogeneity, with the causal mutations being both rare and private, one causal mutation in the prokineticin receptor, PROKR2 L173R, appears unusually prevalent among GnRH-deficient patients of diverse geographic and ethnic origins. To track the genetic ancestry of PROKR2 L173R, haplotype mapping was performed in 22 unrelated patients with GnRH deficiency carrying L173R and their 30 first-degree relatives. The mutation's age was estimated using a haplotype-decay model. Thirteen subjects were informative and in all of them the mutation was present on the same ~123 kb haplotype whose population frequency is ≤10%. Thus, PROKR2 L173R represents a founder mutation whose age is estimated at approximately 9000 years. Inheritance of PROKR2 L173R-associated GnRH deficiency was complex with highly variable penetrance among carriers, influenced by additional mutations in the other PROKR2 allele (recessive inheritance) or another gene (digenicity). The paradoxical identification of an ancient founder mutation that impairs reproduction has intriguing implications for the inheritance mechanisms of PROKR2 L173R-associated GnRH deficiency and for the relevant processes of evolutionary selection, including potential selective advantages of mutation carriers in genes affecting reproduction.

摘要

先天性促性腺激素释放激素(GnRH)缺乏症表现为性成熟缺失或不完全,以及不孕。尽管该疾病表现出明显的基因座和等位基因异质性,其致病突变既罕见又具有个体特异性,但在来自不同地理和种族起源的 GnRH 缺乏症患者中,促动力蛋白受体 PROKR2 的 L173R 突变似乎异常普遍。为了追踪 PROKR2 L173R 的遗传祖先,对 22 名携带 L173R 的 GnRH 缺乏症患者及其 30 名一级亲属进行了单倍型图谱分析。使用单倍型衰减模型估计了突变的年龄。13 名受试者具有信息性,在所有受试者中,突变均存在于相同的约 123 kb 单倍型上,其人群频率≤10%。因此,PROKR2 L173R 代表一个起源于约 9000 年前的创始突变。携带 PROKR2 L173R 相关 GnRH 缺乏症的遗传是复杂的,携带者之间的外显率差异很大,受另一个 PROKR2 等位基因中的额外突变(隐性遗传)或另一个基因(双重性)的影响。这种古老创始突变对生殖造成损害的悖论性发现,对 PROKR2 L173R 相关 GnRH 缺乏症的遗传机制以及相关的进化选择过程具有有趣的启示,包括对生殖相关基因的突变携带者的潜在选择优势。

相似文献

1
An ancient founder mutation in PROKR2 impairs human reproduction.一个古老的 PROKR2 启动子突变会损害人类生殖能力。
Hum Mol Genet. 2012 Oct 1;21(19):4314-24. doi: 10.1093/hmg/dds264. Epub 2012 Jul 5.
2
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.人促性腺激素释放激素缺乏症中前动力蛋白2和前动力蛋白受体2基因的突变:分子遗传学与临床谱
J Clin Endocrinol Metab. 2008 Sep;93(9):3551-9. doi: 10.1210/jc.2007-2654. Epub 2008 Jun 17.
3
Expanding the Spectrum of Founder Mutations Causing Isolated Gonadotropin-Releasing Hormone Deficiency.扩大导致孤立性促性腺激素释放激素缺乏的奠基者突变谱。
J Clin Endocrinol Metab. 2015 Oct;100(10):E1378-85. doi: 10.1210/jc.2015-2262. Epub 2015 Jul 24.
4
PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a Gα-protein leads to biased signaling.PROKR2 基因突变与特发性低促性腺激素性性腺功能减退症:选择性破坏与 Gα-蛋白的结合导致偏向性信号转导。
FASEB J. 2019 Mar;33(3):4538-4546. doi: 10.1096/fj.201801575R. Epub 2018 Dec 21.
5
Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.编码前动力蛋白-2或前动力蛋白受体-2的基因功能丧失突变会导致常染色体隐性卡尔曼综合征。
J Clin Endocrinol Metab. 2008 Oct;93(10):4113-8. doi: 10.1210/jc.2008-0958. Epub 2008 Aug 5.
6
Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency.建立突变型/野生型相互作用模型,以确定 PROKR2 错义变异在孤立性 GnRH 缺乏症患者中的致病性。
Hum Mol Genet. 2018 Jan 15;27(2):338-350. doi: 10.1093/hmg/ddx404.
7
The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.促动力素 2 途径在人类生殖中的作用:来自人类和鼠基因突变研究的证据。
Endocr Rev. 2011 Apr;32(2):225-46. doi: 10.1210/er.2010-0007. Epub 2010 Oct 29.
8
Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways.胚系原动蛋白受体 2(PROKR2)变体与中枢性性腺功能减退症相关,导致不同细胞内途径的不同调节。
J Clin Endocrinol Metab. 2014 Mar;99(3):E458-63. doi: 10.1210/jc.2013-2431. Epub 2013 Nov 25.
9
A genetic basis for functional hypothalamic amenorrhea.功能性下丘脑性闭经的遗传学基础。
N Engl J Med. 2011 Jan 20;364(3):215-25. doi: 10.1056/NEJMoa0911064.
10
PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.与卡尔曼综合征相关的PROKR2错义突变会损害受体信号传导活性。
Hum Mol Genet. 2009 Jan 1;18(1):75-81. doi: 10.1093/hmg/ddn318. Epub 2008 Sep 29.

引用本文的文献

1
Expanding the phenotypic spectrum of PROK2/PROKR2: a recall-by-genotype study.扩展PROK2/PROKR2的表型谱:一项基于基因型的回顾性研究。
Hum Genet. 2025 Jun 11. doi: 10.1007/s00439-025-02754-w.
2
Genetic Polymorphisms of Prokineticins and Prokineticin Receptors Associated with Human Disease.与人类疾病相关的促动力蛋白和促动力蛋白受体的基因多态性
Life (Basel). 2024 Oct 1;14(10):1254. doi: 10.3390/life14101254.
3
Illuminating the terminal nerve: Uncovering the link between GnRH-1 neuron and olfactory development.揭示终神经:揭示 GnRH-1 神经元与嗅觉发育之间的联系。
J Comp Neurol. 2024 Mar;532(3):e25599. doi: 10.1002/cne.25599.
4
High Population Frequency of p.Q106R in Malta: An Evaluation of Fertility and Hormone Profiles in Heterozygotes.马耳他人群中p.Q106R的高频率:杂合子的生育力和激素谱评估
J Endocr Soc. 2023 Dec 29;8(2):bvad172. doi: 10.1210/jendso/bvad172. eCollection 2024 Jan 5.
5
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.靶向促动力素受体在疾病中的治疗潜力。
Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8.
6
Phenotypic and genotypic landscape of PROKR2 in neuroendocrine disorders.PROKR2 在神经内分泌疾病中的表型和基因型全景。
Front Endocrinol (Lausanne). 2023 Feb 8;14:1132787. doi: 10.3389/fendo.2023.1132787. eCollection 2023.
7
Sex differences in the coexpression of prokineticin receptor 2 and gonadal steroids receptors in mice.小鼠中促动力蛋白受体2与性腺甾体激素受体共表达的性别差异。
Front Neuroanat. 2023 Jan 6;16:1057727. doi: 10.3389/fnana.2022.1057727. eCollection 2022.
8
Correlation Analysis of Genotypes and Phenotypes in Chinese Male Pediatric Patients With Congenital Hypogonadotropic Hypogonadism.中国男性儿童先天性低促性腺激素性性腺功能减退症患者基因型与表型的相关性分析。
Front Endocrinol (Lausanne). 2022 May 20;13:846801. doi: 10.3389/fendo.2022.846801. eCollection 2022.
9
One4Two: An Integrated Molecular Approach to Optimize Infertile Couples' Journey.One4Two:优化不孕夫妇生育之旅的综合分子方法。
Genes (Basel). 2021 Jan 2;12(1):60. doi: 10.3390/genes12010060.
10
Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency.建立突变型/野生型相互作用模型,以确定 PROKR2 错义变异在孤立性 GnRH 缺乏症患者中的致病性。
Hum Mol Genet. 2018 Jan 15;27(2):338-350. doi: 10.1093/hmg/ddx404.

本文引用的文献

1
A genetic basis for functional hypothalamic amenorrhea.功能性下丘脑性闭经的遗传学基础。
N Engl J Med. 2011 Jan 20;364(3):215-25. doi: 10.1056/NEJMoa0911064.
2
Expanding the phenotype and genotype of female GnRH deficiency.拓展女性促性腺激素释放激素缺乏症的表型和基因型。
J Clin Endocrinol Metab. 2011 Mar;96(3):E566-76. doi: 10.1210/jc.2010-2292. Epub 2011 Jan 5.
3
The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.促动力素 2 途径在人类生殖中的作用:来自人类和鼠基因突变研究的证据。
Endocr Rev. 2011 Apr;32(2):225-46. doi: 10.1210/er.2010-0007. Epub 2010 Oct 29.
4
Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.孤立性促性腺激素释放激素缺乏症的寡基因基础。
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15140-4. doi: 10.1073/pnas.1009622107. Epub 2010 Aug 9.
5
Deciphering genetic disease in the genomic era: the model of GnRH deficiency.基因组时代的遗传疾病解读:GnRH 缺乏症模型。
Sci Transl Med. 2010 May 19;2(32):32rv2. doi: 10.1126/scitranslmed.3000288.
6
Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations.促性腺激素释放激素受体基因突变患者的基因型和表型。
Front Horm Res. 2010;39:94-110. doi: 10.1159/000312696. Epub 2010 Apr 8.
7
TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood.TAC3/TACR3 突变揭示了神经激肽 B 在新生儿期优先激活促性腺激素释放激素释放,随后在成年期逆转。
J Clin Endocrinol Metab. 2010 Jun;95(6):2857-67. doi: 10.1210/jc.2009-2320. Epub 2010 Mar 23.
8
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.TAC3 和 TACR3 缺陷导致人类下丘脑性先天性性腺功能减退症。
J Clin Endocrinol Metab. 2010 May;95(5):2287-95. doi: 10.1210/jc.2009-2600. Epub 2010 Mar 1.
9
A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.促性腺激素释放激素 2 或促性腺激素释放激素受体 2 基因单等位基因突变和双等位基因突变的卡尔曼综合征患者的表型比较研究。
J Clin Endocrinol Metab. 2010 Feb;95(2):659-69. doi: 10.1210/jc.2009-0843. Epub 2009 Dec 18.
10
Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.胃动素 2 是一种下丘脑神经肽,能强烈抑制食物摄入。
Diabetes. 2010 Feb;59(2):397-406. doi: 10.2337/db09-1198. Epub 2009 Nov 23.